Effect of angiotensin II on vascular remodelling;Effets de l'angiotensine II sur le remodelage vasculaire

Nephrologie

Volumn 19, Issue 7, 1998, Pages 443-449

  Pueyo, M ^a   Michel, J B ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Endothelial cells; Fibroblasts and myofibroblasts; Monocytes; NF kappa B; Phospholipases; Smooth muscle cells; Vascular remodeling

Indexed keywords

ANGIOTENSIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXYGEN RADICAL; PHOSPHOLIPASE C;

ARTERY WALL; ARTICLE; ENDOTHELIUM CELL; FIBROBLAST; MACROPHAGE; MONOCYTE; MYOFIBROBLAST; SMOOTH MUSCLE FIBER; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; VASOMOTOR REFLEX;

ANGIOTENSIN II; ANIMALS; BLOOD VESSELS; ENDOTHELIUM, VASCULAR; HUMANS; MUSCLE, SMOOTH, VASCULAR; OXIDATIVE STRESS; RECEPTORS, ANGIOTENSIN; VASOMOTOR SYSTEM;

EID: 0031733559     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Uehata M, Ishizaki T, Satoh H, Ono T, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997; 389: 990-4.
2. Hu ZW, Shi XY, Okazaki M, Hoffman BB. Angiotensin II induces transcription and expression of alpha-1 adrenergic receptors in vascular smooth muscle cells. Am J Physiol 1995; 268: H1006-H14.
3. Dunn FW, Roux MH, Farhadian F, Sabri K, et al. HR 720 a novel angiotensin receptor antagonist inhibits the angiotensin-II induced trophic effects, fibronectin release and fibronectin-EIIIA+ expression in rat aortic vascular smooth muscle cells in vitro. J Phar Exper Ther 1997; 280:447-53.
4. Bailey WL, Lafleur DW, Forrester JS, Fagin JA, Sharifi BG. Stimulation of rat vascular smooth muscle cell glycosamino glycan production by angiotensin II. Arterosclerosis 1994; 111: 55-64.
5. Powell JS, Clozel JP, Muller RKM, Kuhn R, Hefti F, Hosang M, Baumgartner HR. Inhibitors of angiotensin converting enzyme prevent myointimal proliferation after vascular injury. Science 1989; 245: 186-8.
6. Pawlowski JE, Taylor DS, Valentine M, Hail ME. Ferrer P, Kowala MC, Molloy CJ. Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo. J Clin Invest 1997; 100: 639-48.
7. Du J, Meng XP, Delafontaine P. Transcriptional régulation of insuline-like growth factor-I recpetor gene: Evidence for protein kinase C-dependent and independent pathways. Endocrinology 1996; 137: 1378-81.
8. Alexander RW. Hypertension and the pathogenesis of arterosclerosis, oxydative stress and the mediation of arterial inflammatory response: A new perspective. Hypertension 1995; 25: 155-61.
9. Capers Q, Alexander W, Lou P, De Leon H, et al. Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats. Hypertension 1997; 30: 1397-402.
10. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 1141-8.
11. Pagano PJ, Ito Y, Tornheim K, Crallop PM, Tauler AI, Cohen RA. An NADPH oxidase superoxide-generating system in the rabbit aorta. Am J Physiol 1995; 268: H2274-H80.
12. Rajagopalan SS, Kurz T, Munzel M, Tarpey BA, et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: Contribution to alterations of vasomotor tone. J Clin Invest 1996; 97: 1916-23.
13. Berch-Laursen J, Rajagopalan S, Galis Z, Tarpey M, Freeman BA. Role of superoxide in angiotensin II-induced but not catecholamine induced hypertension. Circulation 1997; 95: 588-93.
14. Fukui T, Ishizaka N, Rajagopalan S, Bech-Laursen J, et al. Griendling. p22phox mRNA expressionand NADPH oxidase activity are increased in aortas from hypertensine rats. Circ Res 1997; 80: 45-51.
15. Puri PL, Avantaggiati ML, Burgio VL, chirillo P, et al. Reactive oxygen intermediates mediate angiotensin II-induced C-jun c-fos heterodimer DNA binding activity and proliferative hypertrophic responses in myogenic cells. J Biol Chem 1995; 270: 22129-34.
16. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulated angiotensin II-induced hypertrophy in vasular smooth muscle cells. J Biol Chem 1996; 271: 23317-21.
17. Stamler J S. Redox signaling: Nitrosylation and related target interactions of nitric oxyde. Cell 1994; 78: 931-6.
18. Buonassi V, Venter JC. Hormone and neurotransmitter receptors in an established vascular endothelial cell line. Proc Natl Acad Sci USA 1976; 73: 1612-6.
19. Gimbrone MA, Alexander RW. Angiotensin stimulation of prostaglandin production in cultured human vascular endothelium. Science 1975; 186: 219-20.
20. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding for the vascular type-1 angiotensin receptor. Nature 1991; 351: 233-6.
21. Feener EP, Nortrup JM, Aiello LP, King JL. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest 1995; 95: 1353-62.
22. Patel JM, Yarid FR, Block ER, Raizada MK. Angiotensin receptors in pulmonary arterial and aortic endothelial cells. Am J Physiol 1989; 256: 987-93.
23. 1 receptors in endothelial cells. Br J Pharmacol 1996; 118: 79-84.
24. Vaughan DE, Lazos SA, Tong K. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. J Clin Invest 1995; 95: 995-1001.
25. 1) receptor gene expression in primilary cultured human arterial umbilical endothelial cells. Biochem Pharmacol 1997; 53: 417-21.
26. Pueyo ME, Arnal JF, Rami J, Michel JB. Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells. Am J Physiol 1998; 274: C214-C20.
27. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995; 95: 651-7.
28. Kerins DM, Hao Q, Vaughan DE. Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. J Clin Invest 1995; 96: 2515-20.
29. Kempf H, Le Moullec JM, Corvol P, Gasc JM. Molecular cloning, expression and tissue distribution of a chicken angiotensin II receptor. FEBS Lett 1997.
30. Nishimura H, Walker OE, Patton CM, Madison AB, Chiu AT, Keiser J. Novel angiotensin receptor subtypes in fowl. Am J Physiol 1994; 267: R1174-R81.
31. 1-mediated release of nitric oxide decreases angiotensin contraction in rat carotid artery. Hypertension 1995; 26: 752-7.
32. 1 subtype receptors in the rat carotid artery. Artenoscler Thromb Vasc Biol 1995; 15: 1646-51.
33. Stanimirovic D, Morley, Ball R, Hamel E, Mealing G, Durkin JP. Angiotensin II-induced fluid phase endocytosis in human cerebromicrovascular endothelial cells is regulated by inositol-phosphate signaling pathway. J Cell Physiol 1996; 169: 455-67.
34. 1 receptors. Hyper Res 1996; 19: 201-6.
35. Olson SC, Dowds TA, Pino PA, Barry MT, Burke-Wolin P. Angiotensin II stimulates endothelial nitric oxide synthase expression in bovin pulmonary artery endothelium. Am J Physiol 1997; 273: L315-L21.
36. Maguess RR, Rosenfeld CR, Hassan A, Paul PW. Endothelial vasodilatator production by uterine and systemic arteries. Effects of ANG-II on PGI2 and NO in pregnancy. Am J Physiol 1996; 270: H1914-H23.
37. Kim JA, Berliner JA, Nadler JL. Angiotensin II increases monocyte binding to endothelial cells. Biochem Biophys Res Comm 1996; 226: 862-8.
38. Imai T, Hirata Y, Emori T, Yanagisawa M, Masaki T, Marumo F. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension 1992; 19: 753-7.
39. Chua CC, Hamdy RC, Chua BH. Angiotensin II induces TIMP-1 production in rat heart endothelial cells. Biochem. Biophys Act 1996; 1311: 175-80.
40. Hasegawa K, Nishimura H, Khosla MC. Angiotensin II-induced endothelium-dependent relaxation of fowl aorta. Am J Physiol 1993; 264: 903-11.
41. Conklin DJ, Olson KR. Angiotensin II relaxation of rainbow trout vessels in vitro. Am J Physiol 1994; 266: R1856-R60.
42. Haberl R, Anneser F, Villringer A, Einhäupl KM. Angiotensin induces endothelium-dependent vasodilatation of rat cerebral arterioles. Am J Physiol 1990; 258: 1840-6.
43. Farber HW, Ceuter DM, Round S. Bovine and human endothelial cell production of neutrophil chemoattractant activity in response to components of the angiotensin system. Circ Res 1985; 57: 898-902.
44. Farber HW, Ceuter DM, Round S, Danilov SM. Component of the angiotensin system cause release of a neutrophil chemoattractant from cultured bovine and human endothelial cells. Eur Heart J 1990: 11 (suppl. B): 100-7.
45. Fernandez LA, Caride VJ, Twickler J, Galardy RE. Renin-angiotensin and development of collateral circulation after renal ischemia. Am J Physiol 1982; 243: H869-75.
46. Fernandez LA, Twickler J, Mead A. Neavascularization produced by angiotensin II. Lab Clin Med 1985; 105: 141-5.
47. Andrade SP, Cardoso CC, Machado RD, Beraldo WT. Angiotensin II-induced angiogenesis in sponge implant in mice. Internat J Microcirc 1996; 16: 302-7.
48. Hu DE, Hiley CR, Pan TP. Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelin-1 and -3 and angiotensin II in a rat sponge model. Br J Pharma 1996; 117: 545-51.
49. Le Noble FA, Kessel-van Wyhick LC, Slaaf HWJ, Oude DW, Egbrink MG, Struijker-Boudier HA. The role of angiotensin II and prostaglandins in arcade formation in a developing microvascular network. J Vasc Res 1996; 33: 480-8.
50. Olsen R. Correlation between infiltration of mononuclear cells and production of connective tissue in acute hypertensive vascular disease. Act Patho. Microbiol Scand 1971; 79: 15-21.
51. Clozel M, Kuhn H, Hefti F, Baumgartner HR. Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Effect of converting enzyme inhibition. Hypertension 1991; 18: 132-41.
52. Hinglais N, Heudes D, Nicoletti A, Mandet C, Laurent M, Bariety J, Michel JB. Co-localization of myocardial fibrosis and inflammatory cells in rats. Lab Invest 1994; 70: 286-94.
53. Nicoletti A, Heudes D, Hinglais N, Appay MD, Philippe M, Prigent-Sassay C, Bariety J, Michel JB. Left ventricular fibrosis in renovascular hypertensive rats. Effets of Losartan and spironolactone. Hypertension 1995; 26: 101-11.
54. Nicoletti A, Heudes D, Mandet C, Hinglais N, Bariety J, Michel JB. Inflammatory cells and myocardial fibrosis: Spatial and temporal distribution in renovascular hypertensive rats. Cardiovasc Res 1996; 32: 1096-107.
55. Nicoletti A, Mandet C, Challah M, Bariety J, Michel JB. Mediators of perivascular inflammation in the left ventricle of renovascular hypertensive rats. Cardiovasc Res 1996; 31: 585-95.
56. Shimada K, Yazaki Y. Binding sites for angiotensin II in human mononuclear leucocytes. J Biochem 1978; 84: 1013-5.
57. Simon MR, Kamlay MT, Khan M, Melmon K. Angiotensin II binding to human mononuclear cells. Immunopharmacol Immun 1989; 11: 63-80.
58. Hahn AW, Jonas U, Buhler FR, Resink TJ. Activation of human peripheral monocytes by angiotensin II. FEBS Letters 1994; 347: 178-80.
59. Lijnen P, Fagard R, Petrov V. Cytosolic calcium changes induced by angiotensin II in human peripheral blood mononuclear cells are mediated via angiotensin II subtype 1 receptors. J Hypert 1997; 15: 871-6.
60. Scheidegger KJ, Butler S, Witztum JL. Angiotensin II increases macrophage-mediated modification of Low Density Lipoprotein via a lipoxygenase-dependent pathway. J Biol Chem 1997; 272: 21609-15.
61. Keidar S, Attias J, Smith J, Breslow JL, Hayek T. The angiotensin II receptor antagonist, losartan, inhibits LDL lipid peroxydation and atherosclerosis in apolipoprotein E-deficient mice. Biochem Biophys Res Comm 1997; 236: 622-5.
62. Elfernik JG, De Koster BM. The stimulation of human neutrophil migration by angiotensin II: Its dependence on Ca++ and the involvement of cyclic GMP. Br J Pharmacol 1997; 121: 643-8.
63. Villareal FJ, Kim NN, Ungab GD, Printz MP, Dillmann WH. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 1993; 88: 2849-61.
64. Nickenig G, Geisen G, Vetter H, Sachinidis A. Characterization of angiotensin receptors on human skin fibroblasts. J Mol Med 1997; 75: 217-22.
65. Sadoshima T, Xu Y., Slayter HS, Izumo S. Autocrine release of angiotensine II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993; 75: 977-84.
66. Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC, Baker KM. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res 1993; 72: 1245-54.
67. Zhou G, Kandala JC, Tyagi SC, Katwa LC, Weber KT. Effect of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts. Mol Cell Biochem 1996; 154: 171-8.
68. Fujisaki H, Ito H, Hirata H, Tanaka M, et al. Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression. J Clin Invest 1995; 96: 1059-65.
69. Sharma HS, Van heugten HA, Goedbloed MA, Verdouw PD, Lamers JM. Angiotensin II induced expression of transforming growth factor-beta 1 mRNA in neonatal cardiac fibroblasts. Biochem Biophys Res Comm 1994; 205: 105-12.
70. Sil P, Sen S. Angiotensin II and myocyte growth: Role of fibroblasts. Hypertension 1997; 30: 209-16.
71. Ponicke K, Heinroth-Hoffmann I, Becker K, Brodde OE. Trophic effect of angiotensin II in neonatal rat cardiomyocytes: role of endothelin-1 and non myocyte cells. Br J Pharmacol 1997; 121: 118-24.